Concord Wealth Partners Catalent, Inc. Transaction History

Concord Wealth Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $25,113 - $32,846	-288 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$94.19 - $124.49 $1,977 - $2,614	21 Added 7.87%	288 $32,000
Q4 2021 Jan 21, 2022	BUY	$119.57 - $139.07 $19,370 - $22,529	162 Added 154.29%	267 $34,000
Q3 2021 Nov 09, 2021	SELL	$109.17 - $142.35 $10,917 - $14,235	-100 Reduced 48.78%	105 $14,000
Q2 2021 Jul 29, 2021	BUY	$100.34 - $115.69 $17,960 - $20,708	179 Added 688.46%	205 $22,000
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $2,639 - $3,257	26 New	26 $3,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.